Guidelines for opioid prescribing in children and adolescents after surgery: an expert panel opinion

LI Kelley-Quon, MG Kirkpatrick, RL Ricca, R Baird… - JAMA …, 2021 - jamanetwork.com
Importance Opioids are frequently prescribed to children and adolescents after surgery.
Prescription opioid misuse is associated with high-risk behavior in youth. Evidence-based …

Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1

AD Kaye, MR Jones, AM Kaye… - Pain …, 2017 - scholarlycommons.pacific.edu
Chronic pain and prescription opioid abuse are extremely prevalent both in this country and
worldwide. Consequences of opioid misuse can be life-threatening with significant morbidity …

Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013

B Saloner, S Karthikeyan - Jama, 2015 - jamanetwork.com
Methods| We used the 2004-2013 rounds of the National Survey of Drug Use and Health
(NSDUH), a nationally representative annual cross-sectional survey of individuals aged 12 …

Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002–11

AW Dick, RL Pacula, AJ Gordon, M Sorbero… - Health …, 2015 - healthaffairs.org
Opioid use disorders are a significant public health problem, affecting two million people in
the United States. Treatment with buprenorphine, methadone, or both is predominantly …

Self-reported treatment need and barriers to care for adults with opioid use disorder: the US national survey on drug use and health, 2015 to 2019

J Saini, B Johnson, DM Qato - American journal of …, 2022 - ajph.aphapublications.org
Objectives. To explore barriers to care and characteristics associated with respondent-
reported perceived need for opioid use disorder (OUD) treatment and National Survey on …

A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees

BD Stein, AW Dick, M Sorbero, AJ Gordon… - Substance …, 2018 - journals.sagepub.com
Background: Medication treatment (MT) with methadone and buprenorphine are effective
treatments for opioid use disorders, but little information is available regarding the extent to …

[PDF][PDF] The economic burden of the opioid epidemic on states: the case of Medicaid

DL Leslie, DM Ba, E Agbese, X Xing… - Am J Manag …, 2019 - ajmc.s3.amazonaws.com
OUD affects 2.5 million Americans1 and is prevalent across all age groups and
backgrounds. It has contributed to increasing injection drug use as well as the spread of …

Barriers to use of pharmacotherapy for addiction disorders and how to overcome them

EM Oliva, NC Maisel, AJ Gordon, AHS Harris - Current psychiatry reports, 2011 - Springer
Substance use disorders are highly prevalent, debilitating conditions for which effective
pharmacotherapies exist with a broad evidence base, yet pharmacotherapy for the treatment …

[HTML][HTML] Trends in engagement with opioid use disorder treatment among Medicaid beneficiaries during the COVID-19 pandemic

AS Tilhou, L Dague, B Saloner, D Beemon… - JAMA Health …, 2022 - jamanetwork.com
Importance Disruptions in care during the COVID-19 pandemic may have decreased access
to care for patients with opioid use disorder. Objective To examine trends in opioid use …

The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine

RE Clark, M Samnaliev, JD Baxter, GY Leung - Health Affairs, 2011 - healthaffairs.org
Many state Medicaid programs restrict access to buprenorphine, a prescription medication
that relieves withdrawal symptoms for people addicted to heroin or other opiates. The …